HIV-1 protease inhibitors and cytomegalovirus vMIA induce mitochondrial fragmentation without triggering apoptosis [2]

Cell Death and Differentiation

Volumn 13, Issue 2, 2006, Pages 348-351

  Roumier, T ^a   Szabadkai, G ^b   Simoni, A M ^b   Perfettini, J L ^a   Paulau, A L ^a   Castedo, M ^a   Metivier D ^a   Badley, A ^c   Rizzuto, R ^b   Kroemer, G ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY OF FERRARA   (Italy)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; HEAT SHOCK PROTEIN 60; INHIBITOR OF APOPTOSIS PROTEIN; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; STAUROSPORINE;

APOPTOSIS; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DIVISION; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE POTENTIAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CYTOMEGALOVIRUS; DRUG MECHANISM; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LETTER; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

APOPTOSIS; CALCIUM; CERAMIDES; CYTOMEGALOVIRUS; GIANT CELLS; HELA CELLS; HIV PROTEASE INHIBITORS; HUMANS; HYDROGEN PEROXIDE; IMMEDIATE-EARLY PROTEINS; INHIBITOR OF APOPTOSIS PROTEINS; MACROPHAGE INFLAMMATORY PROTEINS; MITOCHONDRIA; NELFINAVIR; RITONAVIR; SAQUINAVIR; TUMOR SUPPRESSOR PROTEIN P53; VIRAL PROTEINS;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 30844440999     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401750     Document Type: Letter

References (35)

1. Perfettini J-L et al. (2005) Trends Cell Biol. 15: 179-183
2. Lucken-Ardjomande S and Martinou JC (2005) J. Cell Sci. 118: 473-483
3. Green DR and Kroemer G (2004) Science 305: 626-629
4. Jagasia R et al. (2005) Nature 433: 754-760
5. Labrousse AM et al. (1999) Mol. Cell. 4: 815-826
6. Frank S (2001) Dev. Cell 1: 515-525
7. Szabadkai G et al. (2004) Mol. Cell. 8: 59-68
8. Tolomeo M et al. (2003) J. Clin. Pathol. 56: 147-151
9. Verucchi G et al. (2004) J. Acquir. Immune Defic. Syndr. 35: 326-328
10. Phenix BN (2001) Blood 98: 1078-1085
11. Weaver JGR et al. (2005) J. Clin. Invest. 115: 1828-1938
12. Castedo M and Kroemer G. (2002) Trends Cell Biol. 12: 446-447
13. Castedo M et al. (2002) EMBO J. 21: 4070-4080
14. Badley AD et al. (2003) Trends Pharmacol Sci. 24: 298-305
15. James DI et al. (2003) J. Biol. Chem. 278: 36373-36379
16. Boya P et al. (2005) Mol. Cell. Biol. 25: 1025-1040
17. Roumier T et al. (2003) Biochem. Pharmacol. 66: 1321-1329
18. Castedo M et al. (2002) J. Immunol. Methods 265: 39-47
19. Legros F et al. (2002) Mol. Biol. Cell. 13: 4343-4354
20. Lyamzaev KG et al. (2004) Biochem. Soc. Trans. 32: 1070-1071
21. Pinton P et al. (2001) EMBO J. 20: 2690-2701
22. Garrido C. and Kroemer G (2004) Curr. Opin. Cell Biol. 16: 639-646
23. Danial NN and Korsmeyer S. (2004) Cell 116: 205-219
24. Gerencse AA and Adam-Vizi V (2005) Biophys. J. 88: 698-714
25. Frieden M et al. (2004) J. Biol. Chem. 279: 22704-22714
26. Filippin L et al. (2003) J. Biol. Chem. 278: 39224-39234
27. Goldmacher VS et al. (1999) Proc. Natl. Acad. Sci. USA 96: 12536-12541
28. Poncet D et al. (2004) J. Biol. Chem. 279: 22605-22614
29. McCormick AL et al. (2003) J. Virol. 77: 631-641
30. Lee YL et al. (2004) Mol. Biol. Cell. 15: 5001-5011
31. Castedo M et al. (2004) Oncogene 23: 4362-4370
32. Arnoult D et al. (2004) Proc. Natl. Acad. Sci. USA 101: 7988-7993
33. Bianchi K et al. (2004) Biochim. Biophys. Acta 1742: 119-131
34. Chiesa A et al. (2001) Biochem. J. 355: 1-12
35. Carrington WA et al. (1995) Science 268: 1483-1487